Matches in DBpedia 2014 for { <http://dbpedia.org/resource/Vepalimomab> ?p ?o. }
Showing items 1 to 45 of
45
with 100 items per page.
- Vepalimomab abstract "Vepalimomab is a mouse monoclonal antibody developed for the treatment of inflammations. It blocks the vascular adhesion protein 1.".
- Vepalimomab atcPrefix "none".
- Vepalimomab casNumber "195158-85-1".
- Vepalimomab wikiPageID "9133272".
- Vepalimomab wikiPageRevisionID "555411796".
- Vepalimomab atcPrefix "none".
- Vepalimomab casNumber "195158".
- Vepalimomab chemspiderid "NA".
- Vepalimomab hasPhotoCollection Vepalimomab.
- Vepalimomab mabType "mab".
- Vepalimomab source "o".
- Vepalimomab target AOC3.
- Vepalimomab type "mab".
- Vepalimomab verifiedfields "changed".
- Vepalimomab verifiedrevid "470629578".
- Vepalimomab subject Category:Monoclonal_antibodies.
- Vepalimomab type Abstraction100002137.
- Vepalimomab type Antibody115027189.
- Vepalimomab type Chemical114806838.
- Vepalimomab type Compound114818238.
- Vepalimomab type Macromolecule114944888.
- Vepalimomab type Material114580897.
- Vepalimomab type Matter100020827.
- Vepalimomab type Molecule114682133.
- Vepalimomab type MonoclonalAntibodies.
- Vepalimomab type MonoclonalAntibody115029781.
- Vepalimomab type OrganicCompound114727670.
- Vepalimomab type Part113809207.
- Vepalimomab type PhysicalEntity100001930.
- Vepalimomab type Protein114728724.
- Vepalimomab type Relation100031921.
- Vepalimomab type Substance100019613.
- Vepalimomab type Thing100002452.
- Vepalimomab type Unit109465459.
- Vepalimomab type Drug.
- Vepalimomab type DrugProduct.
- Vepalimomab type FunctionalSubstance.
- Vepalimomab comment "Vepalimomab is a mouse monoclonal antibody developed for the treatment of inflammations. It blocks the vascular adhesion protein 1.".
- Vepalimomab label "Vepalimomab".
- Vepalimomab sameAs m.027yxmm.
- Vepalimomab sameAs Q7920695.
- Vepalimomab sameAs Q7920695.
- Vepalimomab sameAs Vepalimomab.
- Vepalimomab wasDerivedFrom Vepalimomab?oldid=555411796.
- Vepalimomab isPrimaryTopicOf Vepalimomab.